indications for glp 1 agonist indication Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus Figure 2, Health Canada Approval – GLP1-GIP receptor co-agonists: a promising

Understanding the full picture of peptide safety and risks applies here as well, especially if you are using any additional compounds alongside your GLP-1 medication

Potential vitamin D3 injection side effects include: Nausea Vomiting Headaches Constipation Growth problems (in children supplementing vitamin D) Poor appetite or loss of appetite Confusion Fever Decreased sex drive Mood changes Irregular, fast, or slow heartbeat Dry mouth or a metallic taste Disorientation or dizziness Kidney damage Increase in thirst Weight loss Weakness Sleepiness Edema, which is swelling of the ankles, feet, or hands Bone, joint, or muscle pain Vitamin D3 Injections While there are options to supplement vitamin D naturally through food or increased exposure to sunlight, it can also be orally ingested as a pill and injected

longer-term auxological parameters) likely influence the observed effects

SARS-CoV-2-infected patients with COVID-19 disease show alterations in the glucoseinsulin axis leading to hyperglycemia, hyperinsulinemia and insulin resistance, increased oxidative/nitrosative stress, and significantly decreased vitamin D, thiols, total-antioxidant-capacity, GSH and selenium (Soto et al., 2022)

The peptide also supports the growth and development of new brain cells by increasing specific markers like Nestin and GAP43 in human stem cells (4)

Please follow the dosing instructions provided by your healthcare provider to ensure safe and appropriate use